Q

Company Research Report: Qure.ai Technologies Private Limited






1. Company Overview



  • Name: Qure.ai Technologies Private Limited

  • Mission: To use artificial intelligence to make healthcare more accessible and affordable.

  • Founded: 2016

  • Founders: Prashant Warier and Pooja Rao

  • Headquarters: Mumbai, Maharashtra, India

  • Number of Employees: 51-200

  • Revenue: No information is available

  • Key People:

  • Prashant Warier - Founder & CEO

  • Ankit Modi - Chief Product Officer

  • Anushree Saha - General Counsel & Company Secretary

  • Anumeha Srivastava - Chief Business Officer, Neurology

  • Bhargava Reddy - Chief Business Officer, Oncology

  • Bunty Kundnani - Chief Regulatory Affairs Officer

  • Dara Kelleher - VP, Business Development - Global Health

  • Divya Gupta - Chief Business Officer, Global Health

  • Dr. Shibu Vijayan - Chief Medical Officer - Global Health

  • Harsh Vaish - Chief Financial Officer

  • Kaitik Shah - VP, Finance

  • Kautuk Trivedi - Director, Design

  • Poonam Ajgaonkar - Chief People Officer

  • Pradeep Kumar Thummala - Head of Engineering

  • Preetham Putha - Chief AI Officer

  • Surabhi Srivastava - VP, Business Development - UK

  • Notable Recognition: World's most adopted healthcare AI with over +1 billion data sets and +0 million lives impacted in 2600+ sites across 90+ countries.

  • Known For: Leveraging deep learning and AI technology to provide automated interpretation of radiology exams (X-rays, CTs, Ultrasounds) and innovating in healthcare AI.





2. Products and Solutions



Core Products


1. Chest X-Ray Reporting
  • Description: AI solution for comprehensive interpretation of Chest X-rays (qXR).

  • Key Features:

  • Reduces turnaround time for reporting.

  • High Negative Predictive Value (NPV) for segregating unremarkable CXRs.

  • Multilingual support.

  • Automatic report generation.

  • Capable of detecting various lung conditions including tuberculosis and lung nodules.


2. TB Care Cascades
  • Description: AI-powered tool for tuberculosis screening and case management (qTrack).

  • Key Features:

  • Supports all major CR, DR and ultraportable X-rays.

  • Provides real-time notifications.

  • Reduces time to confirmed diagnosis.

  • Multilingual support and flexibility for on-cloud or on-premises deployment.


3. Lung Nodule Management
  • Description: AI solutions for early detection and monitoring of lung nodules.

  • Key Features:

  • Automated discordance framework for uninterrupted workflow.

  • Generates Lung Nodule Malignancy Risk Score.

  • Compatible with standard imaging guidelines.

  • Precise volumetric measurement and characterisation features.


4. Stroke & TBI
  • Description: AI solution for enhancing stroke care and early diagnostics (qER).

  • Key Features:

  • Reduces door-to-treatment time.

  • AI-powered real-time communication tools for stroke management.

  • Seamless integration and data sharing capabilities.

  • FDA cleared for detection of intracranial hemorrhage and other critical findings.


5. MSK X-Ray Reporting
  • Description: AI assistant for trauma musculoskeletal X-rays (qMSK).

  • Key Features:

  • Identifies subtle fractures.

  • Offers bounding box visual aid for radiologists.

  • Reduces diagnostic errors.

  • Supports multiple views.


6. Heart Failure Screening
  • Description: AI tool for incidental detection of heart failure risks on Chest X-rays (qXR-HF).

  • Key Features:

  • Real-time high precision notifications.

  • High sensitivity for cardiomegaly and pleural effusion.

  • Integrates seamlessly with major X-ray systems.


7. Qure AI App
  • Description: Centralized platform for accessing Qure's AI solutions.

  • Key Features:

  • Seamless collaboration and pre-read assistance.

  • Customizable workflows.

  • Mobile support for on-the-go usage.





3. Recent Developments



Recent News and Collaborations


1. Strategic Radiology Collaboration
  • Date: June 18, 2024

  • Description: Partnership with Strategic Radiology to advance clinical accuracy and operational efficiency with AI-integrated imaging solutions bringing tech closer to 1700 radiologists.


2. FDA Approvals
  • Recent Clearance: 13th FDA clearance for qXR-LN, the only FDA-cleared solution for detecting and localizing lung nodules using computer vision.

  • Other Approvals:

  • Heart failure detection on chest X-rays.

  • Pneumothorax and pleural effusion detection, among others.


3. Global Expansion and Awards
  • Recent Wins:

  • Siemens Healthineers Startup Award 2024.

  • Class III medical device license from Health Canada.


Partnerships and Projects


1. Collaborations with AstraZeneca
  • Purpose: To bring AI solutions for early detection of lung cancer across India and other emerging markets.

  • Outcomes: Enhancing early referral and diagnostic pathway, especially targeting underserved communities.


2. Medtronic Partnership
  • Focus: Advanced stroke management.

  • Achievements: Rapid deployment of AI solutions within critical care for faster clinical decision-making.


3. India Health Fund Collaboration
  • Initiatives: Extensive TB screening and tuberculosis care enhancement across 20 states in India.

  • Impact: Screened over 100,000 individuals; notable improvements in TB management efficiency.


4. AI Deployments in Disaster Management
  • Applications: Incorporated AI tools for swift emergency response during pandemics like COVID-19, supporting real-time diagnostics.





In completion of this report, Qure.ai Technologies Private Limited stands out as a leader in healthcare AI, with clear progress in expanding clinical capabilities, regulatory milestones, and impactful partnerships for global health advancements.